Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
849.50    -28.50 (-3.25%)
Bid:
852.50
Ask:
854.50
Spread: 2.00 (0.235%)
Market Cap: £978.40m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Director/PDMR Shareholding

18 Nov 2021 15:34

RNS Number : 8759S
Kainos Group plc
18 November 2021
Β 

18 November 2021

Kainos Group plc

("Kainos" or the "Company")

Β 

Director / PDMR shareholdings

The Company was notified on 18 November 2021 that Tom Burnet, Chairperson and Director of the Company, purchased 13,865 ordinary shares in the Company at an aggregated average price of Β£18.04 per ordinary share.

Following this notification, Tom Burnet has a reportable shareholding of 28,253 ordinary shares in the issued share capital of the Company, constituting 0.023% of the issued share capital of the Company.

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

Β 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Tom Burnet

2.

Reason for the notification

a.

Position/status

Chairperson and Director

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Ordinary Shares of Β£0.005 each

Β 

Β 

KNOS

b.

Nature of the transaction

Purchase of Ordinary Shares

c.

Price(s) and volume(s)

Price(s)

Volume(s)

Β£18.04

13,865

d.

Aggregated information

Β· Aggregated volume

Β· Price

Β 

N/A

e.

Date of the transaction

17-November-2021

f.

Place of the transaction

LSE Regulated Market - XLON

Β 

Kainos Group plc Legal Entity Identifier: 213800H2PQMIF3OVZY47Β 

Β 

Ends

Β 

Β 

For further information, please contact:

Β 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Β 

Investec Bank plc +44Β 20 7597 5970

Patrick Robb / Ben Griffiths

Β 

Canaccord Genuity +44 20 7523 4606

Simon Bridges/ Andrew Potts

Β 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Dwight Burden / Kwaku Aning

Β 

About Kainos

Kainos Group plc is a UK-headquartered IT provider, across two specialist business areas, Digital Services and the Workday Practice.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for public sector, healthcare and commercial customers. These transformative solutions encompass a range of services from experience design to artificial intelligence and cloud to deliver truly intelligent solutions that are secure, accessible and cost-effective.

The Group's Workday Practice is one of Workday's most respected partners. As a full-service partner, we are experienced in complex deployment and integrations, and the leader in Workday test automation.

We're trusted by our customers to launch, test, expand and safeguard their Workday systems. Kainos has over 2,500 people across 17Β offices in Europe, North America, and South America.

Β 

Kainos is listed on the London Stock Exchange (LSE: KNOS).

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHDKFBNPBDDNDD
Date   Source Headline
23rd Aug 20183:40 pmRNSTotal Voting Rights
8th Aug 20182:21 pmRNSDirector/PDMR Shareholding
8th Aug 20182:20 pmRNSDirector/PDMR Shareholding
31st Jul 20183:00 pmRNSAnnual Report and Notice of AGM
24th Jul 20185:41 pmRNSTotal Voting Rights
24th Jul 20183:57 pmRNSDirector/PDMR Shareholding
13th Jul 20187:00 amRNSHolding(s) in Company
4th Jul 20184:51 pmRNSKainos Director/PDMR Shareholding
3rd Jul 201811:54 amRNSKainos Director/PDMR Shareholding
26th Jun 20187:00 amRNSCapital Markets Day
25th Jun 20181:17 pmRNSDirector's Declaration
29th May 20187:00 amRNSPreliminary Results
24th May 20183:08 pmRNSBoard Committee Membership
16th Apr 20187:25 amRNSTrading Update
23rd Mar 20181:06 pmRNSNotification Of Major Holding(s)
23rd Mar 20189:00 amRNSDirector Declaration
22nd Mar 20185:45 pmRNSHolding(s) in Company
23rd Jan 20188:00 amRNSKainos advances digital healthcare transformation
27th Nov 20177:00 amRNSInterim Results
24th Oct 20178:00 amRNSKainos expands its Workday operations in Europe
28th Sep 201711:32 amRNSResult of AGM
4th Sep 20177:00 amRNSTrading Update
17th Aug 20174:32 pmRNSHolding(s) in Company
31st Jul 20173:08 pmRNSAnnual Report 2017 and Notice of AGM
11th Jul 201711:01 amRNSDirector/PDMR shareholdings
6th Jul 20177:00 amRNSFirst Irish customer for Kainos Evolve
3rd Jul 20174:29 pmRNSDirector/PDMR Shareholding
29th Jun 201712:33 pmRNSHolding(s) in Company
30th May 20177:00 amRNSPreliminary Results
12th Apr 20177:00 amRNSTrading Update
27th Mar 201712:01 pmRNSHolding(s) in Company
6th Mar 201710:00 amRNSKainos expands its Workday services in Europe
28th Nov 20167:00 amRNSInterim Results
14th Nov 20167:00 amRNSAppointment of Joint Corporate Broker
2nd Nov 20167:00 amRNSNotice of Results
22nd Sep 20161:45 pmRNSResult of AGM
6th Sep 20167:00 amRNSTrading Update
29th Jul 20165:00 pmRNSAnnual Report 2016 and Notice of AGM
21st Jul 20165:47 pmRNSAward of Shares under SIP and Directors' Dealings
30th Jun 20165:10 pmRNS2016 LTIP Awards - Replacement
30th Jun 20164:25 pmRNS2016 LTIP Awards
13th Jun 20162:27 pmRNSDirector/PDMR Shareholding
9th Jun 20168:00 amRNSKainos appoints new Commercial Client Director
31st May 20167:00 amRNSPreliminary Results
3rd May 20167:00 amRNSNotice of Results
19th Apr 20167:00 amRNSCapital Markets Day
31st Mar 20164:11 pmRNSDirector/PDMR Shareholding
16th Mar 20167:01 amRNSKainos Evolve and InTouch Health Partnership
16th Mar 20167:00 amRNSTrading Update
8th Mar 20161:38 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.